yingweiwo

Others 2

Others 2

Others 2 related products

Structure Cat No. Product Name CAS No. Product Description
(S)-4CPG V3333 (S)-4CPG 134052-73-6 S)-4CPG [also known as (S)-4-Carboxyphenylglycine, and (S)-4C-PG] is a novel, potent,competitive and orally bioactive antagonist of metabotropic glutamate receptor 1 (mGluR) withselectivity for mGluR-1 over mGluR-5.
ARRY-797 V3316 ARRY-797 1036404-17-7 ARRY-797 (also known as ARRY 371797) is a novel, potent and selective inhibitor of p38α (p38 mitogen-activated protein kinase).
B-Raf IN 1 V2975 B-Raf IN 1 950736-05-7 B-Raf IN 1 is a novel, potent and selective B-Raf inhibitor with IC50 of 24 nM; it is equally potent against c-Raf with IC50 of 25 nM.
BT-11 V2989 BT-11 1912399-75-7 This product is discontinued due to commercial reason.
CB-1158 analog V3271 CB-1158 analog 1345810-21-0 CB-1158 analog (CB-1158, INCB01158 or Numidargistat analog) is a potent and orally bioavailable small-molecule inhibitor of the arginase with potential immunomodulating activities.
CP-55940 (CP 55,940) V3362 CP-55940 (CP 55,940) 83002-04-4 CP-55940 (CP-55,940;CP55,940) is a novel, potent and non-selective cannabinoid receptor agonist with Ki values of 0.58 and 0.69 nM for human recombinant CB1 and CB2, respectively.
FIPI HCl V3177 FIPI HCl 1781834-93-2 FIPI HCl, the hydrochloride salt of FIPI which is formerly known as 5-Fluoro-2-indolyl deschlorohalopemide,is a derivative of halopemide which potently and selectively inhibits both PLD1 (phospholipase D) and PLD2 with IC50values of 25 nM and 20 nM, respectively.
GNF-6231 V3197 GNF-6231 1243244-74-7 GNF-6231 is a novel, potent, orally active and selective Porcupine inhibitor that blocks Wnt signaling with IC50 of 0.8 nM (Wnt3a Co-culture RGA).
GSK-962 V3291 GSK-962 2049872-86-6 GSK-962 (also known as GSK962 or GSK962) is a negative control for GSK963 (also known as GSK963 or GSK963).
HDM201 R Enantiomer V3167 HDM201 R Enantiomer 1448867-42-2 HDM201 R Enantiomer is the R enantiomer of HDM201 (also called NVP-HDM201, HDM stands for human double minute 2 homolog).
HUHS015 V2911 HUHS015 1453097-13-6 HUHS015 is a novel and potent inhibitor of PCA-1/ALKBH3 (prostate cancer antigen-1/AlkB Homolog 3) both in vitro and in vivo that was discovered from the optimization of a hit compound identified during random screening using a recombinant PCA-1/ALKBH3.
JWH-133 V3040 JWH-133 259869-55-1 JWH-133 is a synthetic cannabinoid and a potent & selective agonist of the CB2 receptor with a Ki of 3.4nM and selectivity of ~ 200x for CB2 over CB1 receptors.
LGD-3303 V3188 LGD-3303 917891-35-1 LGD-3303is a potent,selective, orally bioavailable, and non-sterdoidal androgen receptor modulator (SARM) with anabolic effects on muscle and cortical bone not observed with bisphosphonates.
Mavorixafor (AMD-070) triHCl V3259 Mavorixafor (AMD-070) triHCl 880549-30-4 MavorixafortriHCl (also known as AMD-1107, AMD070, X4P-001) is a potent, selective and orally bioavailable antagonist ofCXCR4 with anti-HIV activity.
MCOPPB 3HCl V3328 MCOPPB 3HCl 1108147-88-1 MCOPPB 3HCl is a novel and potent nonpeptide agonist of nociceptin receptor with pKi of 10.07 and may be used as an anxiolytic agent.
ML239 V3220 ML239 1378872-36-6 ML239 was originally identified as a potent and selective inhibitor of breast cancer stem cells with an IC50of 1.16 μM, but recent studies (2016 Nature 12(2):109-16.
ML329 V3235 ML329 19992-50-8 ML329 is a potent small molecule inhibitor ofMITF (Micropthalmia-associated transcription factor) which inhibits TRPM-1 (melastatin, a MITF target gene) promoter activity with anIC50of 1.2 μM.
MRK016 HCl V3353 MRK-016 HCl 783331-24-8 MRK-016 HCl (MRK016; MRK 016) is a novel, potent, orally bioactive and selective negative allosteric modulator (inverse agonist) of α5 subunit-containing GABAA with nootropic properties.
NSC23005 V3275 NSC23005 6314-70-1 NSC23005 is a novel and potentp18inhibitor withED50of 5.21 nM in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
NSC23005 sodium V3274 NSC23005 sodium 1796596-46-7 NSC23005 sodium is a novel and potentp18inhibitor withED50of 5.21 nM in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
Contact Us